SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Vabysmo ...

Please provide your email address to receive an email when new articles are posted on . A 78-year-old woman presented to the Lahey Hospital Cornea Service for evaluation and management of new ...

Acute conjunctivitis (“pink eye”) with marginal corneal inflammation Subconjunctival hemorrhage—widely referred to as "red eye"—is the most common ocular problem seen by primary-care clinicians. Red ...

External inspection is essential prior to starting the ophthalmic inspection. One should inspect the head, the scalp, and the periorbital tissue along with the inspections of the globes. The initial ...

Please provide your email address to receive an email when new articles are posted on . Eylea HD was approved for patients with wet age-related macular degeneration, diabetic macular edema and ...

Susvimo was nonferior to intravitreal ranibizumab based on the change from baseline in distance best corrected visual acuity score. The Food and Drug Administration (FDA) has approved Susvimo ® ...

Cases of severe vision loss, inflammation, and potential retinal vasculitis following treatment with Beovu (brolucizumab) injection are currently being investigated by the product’s manufacturer ...